Balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation (TAVI): an opportunity to revisit a previously discouraged treatment option
AbstractBalloon aortic valvuloplasty (BAV) was described in the 1980’s but early enthusiasm was kerbed by results indicating risk of stroke and early restenosis. It therefore fell out of favour and is only indicated as a bridge to defi nitive treatment in the majority of cases. With the advent of transcatheter
aortic valve implantation (TAVI) as a new form of defi nitive treatment in high risk patients with aortic stenosis, there may be a new role for BAV.
Copyright (c) 2017 SA Heart Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This journal is an open access journal, and the authorsÂ and journal should be properly acknowledged, when works are cited.
Authors may use the publishers version for teaching purposes, in books, theses, dissertations, conferences and conference papers.Â
A copy of the authors’ publishers version may also be hosted on the following websites:
- Non-commercial personal homepage or blog.
- Institutional webpage.
- Authors Institutional Repository.Â
The following notice should accompany such a posting on the website: “This is an electronic version of an article published in SAHJ, Volume XXX, number XXX, pages XXX–XXX”, DOI.Â Authors should also supply a hyperlink to the original paper or indicate where the original paper (http://www.journals.ac.za/index.php/SAHJ) may be found.Â
Authors publishers version, affiliated with the Stellenbosch University will be automatically deposited in the University’s’ Institutional Repository SUNScholar.
Articles as a whole, may not be re-published with another journal.
Copyright Holder: SA Heart Journal
The following license applies:
Attribution CC BY-NC-ND 4.0